Robert J. Bitterman is CEO & Chairman +1 at Phio Pharmaceuticals Corp. (PHIO). They have made 20 open-market trades across 2 companies since 2013, most recently 2026-09-11.
CIK 0001304395
20 open-market purchases totalling $84K since 2013, never a sale. Across 16 scored buys the stock is up 1.0% at ninety days, and 0.8 points behind the S&P over the same stretch.
17 scored purchases · one row per filing · discretionary only
| Ticker | Shares | Value |
|---|---|---|
| PHIO | 362,871 | $322K |
| RXII | 10,440 | — |
| Total | $322K |
Shares reported on the most recent Form 4, priced at the 2026-09-15 close. 1 holding could not be priced and is excluded from the total.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| 7d | 30d | 90d | |
|---|---|---|---|
| Accuracy | 0% | 88% | 94% |
| Avg Move | -10.1% | +0.3% | +1.0% |
| Alpha | -48.5% | -1.1% | -0.8% |
| Scored | 17 | 17 | 16 |
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHIO | BUY | 2026-08-18 | 2026-08-19 | $1.06 | $11K | -3.9% | -9.6% | — |
| PHIO | BUY | 2026-06-26 | 2026-06-29 | $0.99 | $10K | +0.0% | -4.5% | -3.4% |
| PHIO | BUY | 2025-12-31 | 2026-01-02 | $1.03 | $5K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2025-12-23 | 2025-12-29 | $1.02 | $5K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2025-11-21 | 2025-11-24 | $1.14 | $6K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2025-11-18 | 2025-11-19 | $1.27 | $6K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2025-06-10 | 2025-06-11 | $2.42 | $5K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2025-06-09 | 2025-06-10 | $2.75 | $4K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2025-05-21 | 2025-05-23 | $1.77 | $7K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2024-06-07 | 2024-06-11 | $0.74 | $740 | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2024-06-06 | 2024-06-10 | $0.75 | $750 | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2024-02-26 | 2024-02-27 | $0.91 | $2K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2023-06-30 | 2023-07-05 | $2.86 | $6K | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2022-12-14 | 2022-12-15 | $0.39 | $780 | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2022-12-07 | 2022-12-08 | $0.39 | $780 | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2022-12-05 | 2022-12-06 | $0.43 | $860 | -11.2% | +1.2% | +1.2% |
| PHIO | BUY | 2022-11-25 | 2022-11-29 | $0.42 | $1K | -11.2% | +1.2% | +1.2% |
| RXII | BUY | 2015-01-22 | 2015-01-23 | $1.20 | $6K | N/A | N/A | N/A |
| RXII | BUY | 2013-08-26 | 2013-08-27 | $3.90 | $2K | N/A | N/A | N/A |
| RXII | BUY | 2013-08-05 | 2013-08-05 | $4.08 | $4K | N/A | N/A | N/A |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.